메뉴 건너뛰기




Volumn 7, Issue 11, 2014, Pages 4272-4281

The clinical effects of dendritic cell vaccines combined with cytokine-induced killer cells intraperitoneal injected on patients with malignant ascites

Author keywords

Cytokine induced killer cell; Cytokines; Dendritic cell; Immunotherapy; Malignant ascites

Indexed keywords

CELL MARKER; DENDRITIC CELL VACCINE; DIURETIC AGENT; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; LACTATE DEHYDROGENASE; LYMPHOTOXIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

EID: 84918568639     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (16)

References (41)
  • 1
    • 0028762425 scopus 로고
    • Care of patients with ascites
    • Runyon BA. Care of patients with ascites. N Engl J Med 1994; 330: 337-342.
    • (1994) N Engl J Med , vol.330 , pp. 337-342
    • Runyon, B.A.1
  • 3
    • 0023766008 scopus 로고
    • Ascitic fluid analysis in malignancy-related ascites
    • Runyon BA, Hoefs JC and Morgan TR. Ascitic fluid analysis in malignancy-related ascites. Hepatology 1988; 8: 1104-1109.
    • (1988) Hepatology , vol.8 , pp. 1104-1109
    • Runyon, B.A.1    Hoefs, J.C.2    Morgan, T.R.3
  • 4
    • 70350616220 scopus 로고    scopus 로고
    • Mana-gement of ascites due to gastrointestinal ma-lignancy (review)
    • Saif MW, Siddiqui IA and Sohail MA. Mana-gement of ascites due to gastrointestinal ma-lignancy (review). Ann Saudi Med 2009; 29: 369-377.
    • (2009) Ann Saudi Med , vol.29 , pp. 369-377
    • Saif, M.W.1    Siddiqui, I.A.2    Sohail, M.A.3
  • 5
    • 77950911606 scopus 로고    scopus 로고
    • Management of drainage for malignant ascites in gynaecological cancer (review)
    • Keen A, Fitzgerald D, Bryant A. Management of drainage for malignant ascites in gynaecological cancer (review). Cochrane Database Syst Rev 2010; 20: CD007794.
    • (2010) Cochrane Database Syst Rev , vol.20 , pp. CD007794
    • Keen, A.1    Fitzgerald, D.2    Bryant, A.3
  • 6
    • 67650744372 scopus 로고    scopus 로고
    • Immune therapy for cancer
    • Dougan M and Dranoff G. Immune therapy for cancer. Annu Rev Immunol 2009; 27: 83-117.
    • (2009) Annu Rev Immunol , vol.27 , pp. 83-117
    • Dougan, M.1    Dranoff, G.2
  • 7
    • 78751628167 scopus 로고    scopus 로고
    • Clinical trials on CIK cells: Fi-rst report of the international registry on CIK cells (IRCC)
    • Hontscha C, Borck Y, Zhou H, Messmer D and Schmidt-Wolf IG. Clinical trials on CIK cells: fi-rst report of the international registry on CIK cells (IRCC). J Cancer Res Clin Oncol 2011; 137: 305-310.
    • (2011) J Cancer Res Clin Oncol , vol.137 , pp. 305-310
    • Hontscha, C.1    Borck, Y.2    Zhou, H.3    Messmer, D.4    Schmidt-Wolf, I.G.5
  • 8
    • 68049140780 scopus 로고    scopus 로고
    • Clinical and immunologic effects of intranodal autologous tumor lysate-dendritic cell vaccine with Aldesleukin (Interleukin 2) and IFN-{al-pha}2a therapy in metastatic renal cell carcinoma patients
    • Schwaab T, Schwarzer A, Wolf B, Crosby NA. Clinical and immunologic effects of intranodal autologous tumor lysate-dendritic cell vaccine with Aldesleukin (Interleukin 2) and IFN-{al-pha}2a therapy in metastatic renal cell carcinoma patients. Clin Cancer Res 2009; 15: 4986-4992.
    • (2009) Clin Cancer Res , vol.15 , pp. 4986-4992
    • Schwaab, T.1    Schwarzer, A.2    Wolf, B.3    Crosby, N.A.4
  • 9
    • 0036197888 scopus 로고    scopus 로고
    • Immunology of the peritoneal cavity: Relevance for host-tumor relation
    • Melichar B and Freedman RS. Immunology of the peritoneal cavity: relevance for host-tumor relation. Int J Gynecol Cancer 2002; 12: 3-17.
    • (2002) Int J Gynecol Cancer , vol.12 , pp. 3-17
    • Melichar, B.1    Freedman, R.S.2
  • 10
    • 0025856106 scopus 로고
    • Use of a SCID mouseihuman lymphoma model to evaluate cytokine-induced killer cells with potent antitumour cell activity
    • Schmidt-Wolf IG, Negrin RS, Kiem HP, Blume KG and Weissman IL. Use of a SCID mouseihuman lymphoma model to evaluate cytokine-induced killer cells with potent antitumour cell activity. J Exp Med 1991; 174: 139-149.
    • (1991) J Exp Med , vol.174 , pp. 139-149
    • Schmidt-Wolf, I.G.1    Negrin, R.S.2    Kiem, H.P.3    Blume, K.G.4    Weissman, I.L.5
  • 11
  • 13
    • 0028103808 scopus 로고
    • A novel population of expanded human CD3+ CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency
    • Lu PH and Negrin RS. A novel population of expanded human CD3+ CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency. J Immunol 1994; 153: 1687-1696.
    • (1994) J Immunol , vol.153 , pp. 1687-1696
    • Lu, P.H.1    Negrin, R.S.2
  • 15
    • 0032211175 scopus 로고    scopus 로고
    • Expansion of Philadelphia ch-romosome-negative CD3+ CD56+ cytotoxic ce-lls from chronic myeloid leukemiapatients: In vitro and in vivo efficacy in severe combined immunodeficiency disease mice
    • Hoyle C, Bangs C, Mehta B, Chang P, Kamel O and Negrin RS. Expansion of Philadelphia ch-romosome-negative CD3+ CD56+ cytotoxic ce-lls from chronic myeloid leukemiapatients: in vitro and in vivo efficacy in severe combined immunodeficiency disease mice. Blood 1998; 92: 3318-3327.
    • (1998) Blood , vol.92 , pp. 3318-3327
    • Hoyle, C.1    Bangs, C.2    Mehta, B.3    Chang, P.4    Kamel, O.5    Negrin, R.S.6
  • 19
    • 79961105556 scopus 로고    scopus 로고
    • Omental milky spots in screening gastric cancer stem cells
    • Cao L, Hu X, Zhang Y, Sun XT. Omental milky spots in screening gastric cancer stem cells. Neoplasma 2011; 58: 20-26.
    • (2011) Neoplasma , vol.58 , pp. 20-26
    • Cao, L.1    Hu, X.2    Zhang, Y.3    Sun, X.T.4
  • 20
    • 18844483161 scopus 로고    scopus 로고
    • Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin-2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinomatosis
    • Freedman RS, Kudelka AP, Kavanagh JJ. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin-2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinomatosis. Clin Ca-ncer Res 2000; 6: 2268-2278.
    • (2000) Clin Ca-ncer Res , vol.6 , pp. 2268-2278
    • Freedman, R.S.1    Kudelka, A.P.2    Kavanagh, J.J.3
  • 21
    • 4644237613 scopus 로고    scopus 로고
    • Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
    • Curiel TJ, Coukos G, Zou L. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004; 10: 942-949.
    • (2004) Nat Med , vol.10 , pp. 942-949
    • Curiel, T.J.1    Coukos, G.2    Zou, L.3
  • 22
    • 34250159834 scopus 로고    scopus 로고
    • Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+ CD56+ cells with platinum resistance
    • Bamias A, Tsiatas ML, Kafantari E. Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+ CD56+ cells with platinum resistance. Gynecol Oncol 2007; 106: 75-81.
    • (2007) Gynecol Oncol , vol.106 , pp. 75-81
    • Bamias, A.1    Tsiatas, M.L.2    Kafantari, E.3
  • 23
    • 0030610251 scopus 로고    scopus 로고
    • Differences in the recognition of tumor-specific CD8+ T cells derived from solid tumor, metastatic lymph nodes and ascites in patients with gastric cancer
    • Kono K, Ichihara F, Izuka H, Sekikawa T and Matsumoto Y. Differences in the recognition of tumor-specific CD8+ T cells derived from solid tumor, metastatic lymph nodes and ascites in patients with gastric cancer. Int J Cancer 1997; 71: 978-981.
    • (1997) Int J Cancer , vol.71 , pp. 978-981
    • Kono, K.1    Ichihara, F.2    Izuka, H.3    Sekikawa, T.4    Matsumoto, Y.5
  • 24
    • 0019969717 scopus 로고
    • Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2
    • Eberlein TJ, Rosenstein M and Rosenberg SA. Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2. J Exp Med 1982; 156: 385-397.
    • (1982) J Exp Med , vol.156 , pp. 385-397
    • Eberlein, T.J.1    Rosenstein, M.2    Rosenberg, S.A.3
  • 25
    • 5144226237 scopus 로고    scopus 로고
    • Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes
    • Rosenberg SA and Dudley ME. Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes. Proc Natl Acad Sci U S A 2004; 101 Suppl 2: 14639-14645.
    • (2004) Proc Natl Acad Sci U S A , vol.101 , pp. 14639-14645
    • Rosenberg, S.A.1    Dudley, M.E.2
  • 26
    • 20244366111 scopus 로고    scopus 로고
    • Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma
    • Dudley ME, Wunderlich JR, Yang JC. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol 2005; 23: 2346-2357.
    • (2005) J Clin Oncol , vol.23 , pp. 2346-2357
    • Dudley, M.E.1    Wunderlich, J.R.2    Yang, J.C.3
  • 27
    • 84890452839 scopus 로고    scopus 로고
    • Adoptive cell therapy: Honing that killer instinct
    • Humphries C. Adoptive cell therapy: Honing that killer instinct. Nature 2013; 504: S13-5.
    • (2013) Nature , vol.504 , pp. S13-S15
    • Humphries, C.1
  • 28
    • 0028069489 scopus 로고
    • Large-scale expansion in interleukin-2 of tumor-infiltrating lymphocytes from patients with ovarian carcinoma for adoptive immunotherapy
    • Freedman RS, Tomasovic B, Templin S. Large-scale expansion in interleukin-2 of tumor-infiltrating lymphocytes from patients with ovarian carcinoma for adoptive immunotherapy. J Im-munol Methods 1994; 197: 145-160.
    • (1994) J Im-munol Methods , vol.197 , pp. 145-160
    • Freedman, R.S.1    Tomasovic, B.2    Templin, S.3
  • 29
    • 0025076560 scopus 로고
    • trial of intraperitoneal recombinant interleukin-2/lymphokineactivated killer cells in patients with ovarian cancer
    • Stewart JA, Belinson JL, Moore AL. Phase I trial of intraperitoneal recombinant interleukin-2/lymphokineactivated killer cells in patients with ovarian cancer. Cancer Res 1990; 50: 6302-6310.
    • (1990) Cancer Res , vol.50 , pp. 6302-6310
    • Stewart, J.A.1    Belinson, J.L.2    Moore, A.L.3    Phase, I.4
  • 30
    • 0024996777 scopus 로고
    • Intrape-ritoneal lymphokine-activated killer-cell and interleukin-2 therapy for malignancies limited to the peritoneal cavity
    • Steis RG, Urba WJ, VanderMolen LA. Intrape-ritoneal lymphokine-activated killer-cell and interleukin-2 therapy for malignancies limited to the peritoneal cavity. J Clin Oncol 1990; 8: 1618-1629.
    • (1990) J Clin Oncol , vol.8 , pp. 1618-1629
    • Steis, R.G.1    Urba, W.J.2    Vandermolen, L.A.3
  • 31
    • 0026579264 scopus 로고
    • Adoptive immunotherapy with activated macrophages grown in vitro from blood monocytes in cancer patients: A pilot study
    • Lopez M, Fechtenbaum J, David B. Adoptive immunotherapy with activated macrophages grown in vitro from blood monocytes in cancer patients: a pilot study. J Immunother 1992; 11: 209-217.
    • (1992) J Immunother , vol.11 , pp. 209-217
    • Lopez, M.1    Fechtenbaum, J.2    David, B.3
  • 32
    • 33644530039 scopus 로고    scopus 로고
    • Unexpected long-term survival after low-dose palliative radiotherapy for non-small cell lung cancer
    • Mac Manus MP, Matthews JP, Worotniuk V and Ball DL. Unexpected long-term survival after low-dose palliative radiotherapy for non-small cell lung cancer. Cancer 2006; 106: 1110-1116.
    • (2006) Cancer , vol.106 , pp. 1110-1116
    • Mac Manus, M.P.1    Matthews, J.P.2    Worotniuk, V.3    Ball, D.L.4
  • 34
    • 0029997017 scopus 로고    scopus 로고
    • De-ndritic cells in antitumor immune response. I. Defective antigen presentation in tumor-bearing hosts
    • Gabrilovich DI, Ciernik IF and Carbone DP. De-ndritic cells in antitumor immune response. I. Defective antigen presentation in tumor-bearing hosts. Cell Immunol 1996; 170: 101-110.
    • (1996) Cell Immunol , vol.170 , pp. 101-110
    • Gabrilovich, D.I.1    Ciernik, I.F.2    Carbone, D.P.3
  • 35
    • 0029893672 scopus 로고    scopus 로고
    • Dendritic cells in antitumor responses. II. Dendritic cells grown from bone marrow precursor, but not mature DC form tumor-bearing mice, are effective antigen carriers in the therapy of established tumors
    • Gabrilovich DI, Nadaf S, Corak J, Berzofsky JA and Carbone DP. Dendritic cells in antitumor responses. II. Dendritic cells grown from bone marrow precursor, but not mature DC form tumor-bearing mice, are effective antigen carriers in the therapy of established tumors. Cell Immunol 1996; 170: 111-119.
    • (1996) Cell Immunol , vol.170 , pp. 111-119
    • Gabrilovich, D.I.1    Nadaf, S.2    Corak, J.3    Berzofsky, J.A.4    Carbone, D.P.5
  • 36
    • 33846937046 scopus 로고    scopus 로고
    • CXC chemokine ligand 9/monokine induced by IFN-gamma production by tumor cells is critical for T cell-mediated suppression of cutaneous tumors
    • Gorbachev AV, Kobayashi H, Kudo D, Tanne-nbaum CS, Finke JH, Shu S. CXC chemokine ligand 9/monokine induced by IFN-gamma production by tumor cells is critical for T cell-mediated suppression of cutaneous tumors. J Im-munol 2007; 178: 2278-2286.
    • (2007) J Im-munol , vol.178 , pp. 2278-2286
    • Gorbachev, A.V.1    Kobayashi, H.2    Kudo, D.3    Tanne-Nbaum, C.S.4    Finke, J.H.5    Shu, S.6
  • 37
    • 33748756028 scopus 로고    scopus 로고
    • TGF-be-ta: A mobile purveyor of immune privilege
    • Wahl SM, Wen J and Moutsopoulos N. TGF-be-ta: a mobile purveyor of immune privilege. Immunol 2006; 213: 213-227.
    • (2006) Immunol , vol.213 , pp. 213-227
    • Wahl, S.M.1    Wen, J.2    Moutsopoulos, N.3
  • 38
    • 33845678877 scopus 로고    scopus 로고
    • Role of transforming growth factor-beta in cancer progression
    • Galliher AJ, Neil JR and Schiemann WP. Role of transforming growth factor-beta in cancer progression. Future Oncol 2006; 2: 743-763.
    • (2006) Future Oncol , vol.2 , pp. 743-763
    • Galliher, A.J.1    Neil, J.R.2    Schiemann, W.P.3
  • 39
    • 0026927829 scopus 로고
    • Presence of interleukin-10 (IL-10) in the ascites of patients with ovarian and other intraabdominal cancers
    • Gotlieb WH, Abrams JS, Watson JM, Velu TJ, Berek JS and Martinez-Maza O. Presence of interleukin-10 (IL-10) in the ascites of patients with ovarian and other intraabdominal cancers. Cytokine 1992; 4: 385-390.
    • (1992) Cytokine , vol.4 , pp. 385-390
    • Gotlieb, W.H.1    Abrams, J.S.2    Watson, J.M.3    Velu, T.J.4    Berek, J.S.5    Martinez-Maza, O.6
  • 40
    • 0035885327 scopus 로고    scopus 로고
    • Paracrine angiogenic loop between head-and-neck squamous-cell carcinomas and macrophages
    • Liss C, Fekete MJ, Hasina R, Lam CD and Lingen MW. Paracrine angiogenic loop between head-and-neck squamous-cell carcinomas and macrophages. Int J Cancer 2001; 93: 781-785.
    • (2001) Int J Cancer , vol.93 , pp. 781-785
    • Liss, C.1    Fekete, M.J.2    Hasina, R.3    Lam, C.D.4    Lingen, M.W.5
  • 41


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.